Biliary dysfunction (according to recommendations of Rome IV): diagnosis, treatment
https://doi.org/10.33667/2078-5631-2020-10-5-10
Abstract
The paper presents information on modern functional disorders of the gastrointestinal tract and biliary system, based on the recommendations of the Rome IV. Own studies on the effectiveness of treatment of biliary functional disorders with Niaspam (mebeverine hydrochloride) are presented. We studied 30 patients with biliary pain and functional disorders of the gallbladder. As a result of studies, it was found that the symptoms of biliary dysfunction stop in 83.3 % of patients, the contractility of the gallbladder is restored in 86.7 %. No side effects have been reported.
About the Authors
O. N. Minushkin
Central State Medical Academy of the Administrative Department of the President of Russia
Russian Federation
Russian Federation
Moscow
L. V. Maslovsky
Central State Medical Academy of the Administrative Department of the President of Russia
Russian Federation
Russian Federation
Moscow
N. V. Lvova
Centre for Research and Practice in Medical Rehabilitation, Restorative and Sports Medicine
Russian Federation
Russian Federation
Moscow
K. S. Legkova
Central State Medical Academy of the Administrative Department of the President of Russia
Russian Federation
Russian Federation
Moscow
E. S. Gordienko
Central State Medical Academy of the Administrative Department of the President of Russia
Russian Federation
Russian Federation
Moscow
O. A. Protsenko
Central State Medical Academy of the Administrative Department of the President of Russia
Russian Federation
Russian Federation
Moscow
A. V. Magomedrasulova
Central State Medical Academy of the Administrative Department of the President of Russia
Russian Federation
Russian Federation
Moscow
O. F. Shaposhnikova
Central State Medical Academy of the Administrative Department of the President of Russia
Russian Federation
Russian Federation
Moscow
References
1. Drossman D. A. Functional gastrointestinol disorders: history, pathophysiology, clinical teatures and Rome ІV. Gastroenterology. 2016, 150, 1262–1979.
2. Минушкин О. Н. Фармакологические подходы к лечению сочетанной функциональной патологии (билиарной и кишечной). Медицинский совет, 2018, 14, 78–82.
3. Маев И. В., Кучерявый Ю. А., Цуканов В. В. и др. Результаты проспективной наблюдательной программы «Одиссей»: эффективность мебеверина у пациентов с постхолецистэктомическими спазмами. Терапевтический архив; 2018, Т. 90, № 8, 40–47.
4. Степанова Е. В., Лоранская И. Д., Ракитская Л. Г., Мамедова Л. Д. Билиарные дисфункции. Эффективность спазмолитической терапии. Эффективная фармакология. 2020, Т. 16, № 1, 62–70.
5. Минушкин О. Н. Синдром после холецистэктомии в практике терапевта и гастроэнтеролога. Лечащий врач. 2015, № 2, 40–46.
Review
For citations:
Minushkin O.N., Maslovsky L.V., Lvova N.V., Legkova K.S., Gordienko E.S., Protsenko O.A., Magomedrasulova A.V., Shaposhnikova O.F. Biliary dysfunction (according to recommendations of Rome IV): diagnosis, treatment. Medical alphabet. 2020;(10):5-10. (In Russ.) https://doi.org/10.33667/2078-5631-2020-10-5-10
Views:
594
Email this article 